Pharma • Biotech • Industry Partners
Explore the companies pioneering cancer therapeutics, diagnostics, and clinical innovation worldwide
From immunotherapy giants to cutting-edge biotech startups, the oncology ecosystem is driven by companies developing new treatments, diagnostics, and delivery platforms. This directory highlights leading pharma, biotech, and industry partners contributing to breakthrough cancer care — including CAR-T therapies, targeted drugs, radiopharmaceuticals, AI diagnostics, and next-generation clinical technologies.
Major Global Pharma Leaders in Oncology
Switzerland/USA
Focus:
Immunotherapy, targeted therapies, diagnostics
Key Drugs/Products:
Herceptin, Tecentriq, Avastin
Why it matters:
Largest oncology pharmaceutical portfolio in the world.
Switzerland
Focus:
CAR-T, molecular targeted therapy
Key Drugs/Products:
Kymriah (first FDA-approved CAR-T), Kisqali
Why it matters:
Leader in cell therapy manufacturing and radiopharmaceuticals.
USA
Focus:
Immuno-oncology
Key Drugs/Products:
Keytruda (highest-selling cancer drug globally)
Why it matters:
Massive clinical trial footprint, global research collaboration.
USA
Focus:
Immunotherapy, cell therapy
Key Drugs/Products:
Opdivo, Yervoy, Breyanzi
Why it matters:
Strong PD-1/CTLA-4 pipeline, major trial sponsor.
UK
Focus:
Targeted oncology, antibody-drug conjugates (ADCs)
Key Drugs/Products:
Tagrisso, Imfinzi, Enhertu (partnered with Daiichi)
Why it matters:
Top innovator in EGFR & HER2 precision oncology.
USA
Focus:
Targeted therapies, breast cancer drugs
Key Drugs/Products:
Ibrance
Why it matters:
Expanding radiopharmaceutical portfolio.
Next-Generation Biotech Innovators
USA
Focus:
CAR-T cell therapy
Key Drugs/Products:
Yescarta
Why it matters:
Leading global CAR-T manufacturer.
USA
Focus:
Immuno-oncology
Key Drugs/Products:
Strong bispecific antibody pipeline
Why it matters:
Strong bispecific antibody pipeline.
USA
Focus:
Targeted small-molecule cancer therapies
Key Drugs/Products:
Cabozantinib
Why it matters:
Cabozantinib success & broad precision oncology research.
China/USA
Focus:
Immunotherapy, targeted therapy
Key Drugs/Products:
Tislelizumab
Why it matters:
Major global expansion and low-cost trial innovation.
China
Focus:
PD-1 inhibitors and precision drugs
Key Drugs/Products:
Sintilimab
Why it matters:
Makes immunotherapy more accessible globally.
Japan
Focus:
ADCs (Antibody-Drug Conjugates)
Key Drugs/Products:
Enhertu (with AstraZeneca)
Why it matters:
Collaborator with AstraZeneca for Enhertu, one of the most important modern oncology drugs.
Radiopharmaceutical & Theranostics Companies
USA
Focus:
Diagnostic radiopharma
Key Drugs/Products:
PSMA PET imaging tools
Why it matters:
Leading developer of PSMA PET imaging tools.
Europe/USA
Focus:
Radiopharmaceutical diagnostics
Key Drugs/Products:
Cancer imaging agents
Why it matters:
Major supplier for cancer imaging worldwide.
Australia
Focus:
Targeted radionuclide therapy
Key Drugs/Products:
Prostate cancer therapies
Why it matters:
Transforming targeted radionuclide therapy.
USA
Focus:
Precision radiopharmaceuticals
Key Drugs/Products:
Peptide-based targeted therapies
Why it matters:
Groundbreaking work in peptide-based targeted therapies.
USA/Canada
Focus:
Targeted radionuclide therapy
Key Drugs/Products:
Late-stage trials
Why it matters:
Late-stage radiopharmaceutical trials gaining global attention.
AI, Software & Diagnostics Partners
USA
Focus:
Real-world oncology data
Key Drugs/Products:
Data platform
Why it matters:
Foundation for data-driven cancer research.
USA
Focus:
Precision data + genomic sequencing
Key Drugs/Products:
Genomic platform
Why it matters:
Links clinical data and tumor genomics in real time.
USA
Focus:
AI pathology
Key Drugs/Products:
Diagnostic AI
Why it matters:
Improves diagnosis accuracy and clinical workflows.
China
Focus:
AI imaging
Key Drugs/Products:
Radiology AI
Why it matters:
Growing global footprint in radiology cancer detection.
Global Clinical Trial Sponsors
Partner With Us
Access data intelligence, clinical trial insights, and global research updates for your oncology pipeline